Exact Sciences diskutieren
Exact Sciences
WKN: 590273 / Symbol: EXAS / Name: EXACT Sci / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
87,67 €
0,02 %
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Evercore ISI from $72.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Sanford C. Bernstein from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Robert W. Baird from $70.00 to $67.00. They now have an "outperform" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Benchmark Co. from $67.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Craig Hallum from $82.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Evercore ISI from $80.00 to $60.00. They now have an "outperform" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $75.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at TD Cowen from $90.00 to $82.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Stifel Nicolaus from $82.00 to $67.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at BTIG Research from $82.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Jefferies Financial Group Inc. from $84.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Piper Sandler from $85.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at BTIG Research from $65.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at TD Cowen from $82.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Bank of America Co. from $75.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $65.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Barclays PLC from $70.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Bank of America Co. from $72.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in KKR & Co. LP diskutieren